Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize ...

Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging ...

There was a substantial increase in recent years in the use of a form of the primary medication to treat opioid use disorder, ...

THE nation's efforts to reduce prison overcrowding by reopening a colonial jail and recruiting more staff after a deadly riot left 28 people dead need to be underpinned by a commitment to ...

Conexeu Completes 12-Month Preclinical P.R.O.O.F Study, Supporting Its Intended Move Into the $11 Billion Medical Aesthetics Market as a Platform¹ ...

The in vitro experiments that used the artificial genetic codes tested here did not provide support for the error minimization theory.

Marijuana legalization in the United States began as a patient-rights movement, grew into a state-by-state challenge to ...

Reg Wydeven is a partner with the Appleton-based law firm of McCarty Law LLP. He writes a weekly column for The Post-Crescent ...

In a position statement published earlier this year, the American College of Clinical Pharmacy called for the total ...

The FDA has proposed a new rule that would seek to eliminate the adequate provision guidance in pharma DTC ads.

The man accused of killing a traveling salesman at hotel in Ohio 40 years ago pleaded not guilty in court on Tuesday.

After several months of AbbVie leading pharma’s monthly ad spend, Johnson & Johnson is back as Tremfya topped June’s rankings ...